Stanford Medical School Shield
 
ARAMIS button
investigators button
research button
publications button
HAQ button
pharmaceutical collaborations button
 
Link to Main Stanford Medical School Site
 Heading Filler Publications Page Heading
Clear Spacer  
 

    Thomas A. Medsger

  • Steen V, Medsger TA Jr. Predicators of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48:516-522, 2003.
  • Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 48:203-209, 2003.
  • Steen VD, Medsger, Jr TA. Improvement in Skin Thickening in Systemic Sclerosis Associated With Improved Survival. Arthritis Rheum. 2001;44(12):2828-2835.
  • Kuwana M, Feghali CA, Medsger TA Jr., Wright TM: Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum 44:1654-1659, 2001.
  • Tomaino MM, Goitz RJ, Medsger TA Jr. Surgery for ischemic pain and Raynaud’s phenomenon in scleroderma: a description of treatment protocol and evaluation of results. J Microsurgery 21(3):75-9, 2001.
  • Gunduz OH, Fertig N, Lucas M, Medsger TA Jr. Systemic sclerosis with renal crisis and pulmonary hypertension. Arthritis Rheum 44:1663-1666, 2001.
  • Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 44:2828-2835, 2001.
  • Medsger TA Jr, Lucas M, Wildy KS, Baker C. D-penicillamine in systemic sclerosis? Yes! Scandinavian Journal of Rheumatology 30(4):192-194, 2001.
  • Kuwana M, Medsger TA Jr, Wright TM: Analysis of soluble and cell surface factors regulating anti-DNA topoisomerse I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J Immunol 164:6138-6146, 2000.
  • Poormoghim H, Lucas M, Fertig N, Medsger TA Jr: Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43:444-451, 2000.
  • Falkner D, Wilson JW, Fertig N, Clawson K, Medsger TA Jr, Morel PA: Studies of HLA-DR AND DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). J Rheumatol 27:1196-1202, 2000.
  • Steen VD, Medsger TA Jr: Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437-2444, 2000.
  • Steen VD, Medsger TA Jr: Long term outcome of scleroderma renal crisis. Ann Intern Med 133(8):600-3, 2000.
  • Steen V, Medsger T. Risk factors for the development of isolated pulmonary hypertension (PHT) in systemic sclerosis (SSC). Arthritis Rheum. 1999;42:S189.
  • Steen V, Medsger T. Survival of patients with systemic and scleroderma specific autoantibodies. Arthritis Rheum. 1999;42:S189.
  • Steen VD, Medsger TA, Jr. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 1999;42(4):763-8.
  • Sampalis JS, Medsger TA, Fries JF, et al. Risk factors for adult Still's disease. J Rheumatol. 1996;23(12):2049-54.
  • Clarke AE, Bloch DA, Medsger TA, Jr., Oddis CV. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum. 1995;38(9):1218-24.
  • Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum. 1995;38(8):1120-7.
  • Sampalis JS, Esdaile JM, Medsger TA, et al. A controlled study of the long-term prognosis of adult Still's disease. Am J Med. 1995;98(4):384-8.
  • Clauw DJ, Flockhart DA, Mullins W, Katz P, Medsger TA. Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements. J Rheumatol. 1994;21(12):2385-7.
  • Fries JF, Hochberg MC, Medsger TA, Hunder GG, Bombardier C. Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1994;37(4):454-62.
  • Steen VD, Lanz JK, Jr., Conte C, Owens GR, Medsger TA, Jr. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum. 1994;37(9):1290-6.
  • Okano Y, Steen VD, Medsger TA. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119(10):1005-13.
  • Fries JF, Seibold JR, Medsger TA. Photopheresis for scleroderma? No! J Rheumatol. 1992;19(7):1011-3.
  • Hibbs JR, Mittleman B, Hill P, Medsger TA. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Arthritis Rheum. 1992;35(3):299-303.
  • Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum. 1992;35(10):1211-7.
  • Okano Y, Steen VD, Medsger TA. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 1992;35(1):95-100.
  • Ramsey-Goldman R, Kutzer JE, Kuller LH, Guzick D, Carpenter AB, Medsger TA, Jr. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol. 1992;28(3-4):195-8.
  • Steen VD, Graham G, Conte C, Owens G, Medsger TA, Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum. 1992;35(7):765-70.
  • Altman RD, Medsger TA, Jr., Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum. 1991;34(4):403-13.
  • Manzi S, Urbach AH, McCune AB, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum. 1991;34(1):101-5.
  • Medsger TA. Treatment of systemic sclerosis. Ann Rheum Dis. 1991;50 Suppl 4:877-86.
  • Oddis C, Medsger T. Chronic inflammatory myopathies: polymyositis and dermatomyositis. Part 2. Jnl of Musculoskeletal Medicine. 1991;4:31-42.
  • Oddis C, Medsger T. Chronic inflammatory myopathies: polymyositis and dermatomyositis. Part 1 Muscle. Jnl of Musculoskeletal Medicine. 1991;3:26-37.
  • Okano Y, Medsger TA. Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis. J Immunol. 1991;146(2):535-42.
  • Falanga V, Medsger TA. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol. 1990;126(5):609-12.
  • Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol. 1990;17(5):656-62.
  • Helfrich D, Londino A, Steen V, Medsger T. Systemic sclerosis with onset in childhood. Arthritis Rheum. 1990;33:S144.
  • Medsger T. L-trytophan-induced eosinophilia-myalgia syndrome. New Engl Jnl of Medicine. 1990;322:926-928.
  • Oddis CV, Conte CG, Steen VD, Medsger TA. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990;17(10):1329-34.
  • Oddis CV, Medsger TA, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum. 1990;33(11):1640-5.
  • Okano Y, Medsger TA. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990;33(12):1822-8.
  • Steen VD, Costantino JP, Shapiro AP, Medsger TA, Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med. 1990;113(5):352-7.
  • Steen VD, Medsger TA, Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990;16(1):1-10.
  • Cohen S, Deng J, Steen V, Medsger T. D-penicillamine induced lupus syndrome in systemic sclerosis patients. Arthritis Rheum. 1989;32:S93.
  • Engel E, Charley M, Steen V, Medsger T. Solubale interleukin-2 receptors (ll2R) in diffuse cutaneous systemic sclerosis. Arthritis Rheum. 1989;32:S42.
  • Helfrich DJ, Banner B, Steen VD, Medsger TA. Normotensive renal failure in systemic sclerosis. Arthritis Rheum. 1989;32(9):1128-34.
  • Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol. 1989;16(4):427-41.
  • Oddis CV, Medsger TA. Current management of polymyositis and dermatomyositis. Drugs. 1989;37(3):382-90.
  • Steen V, Conte C, Day N, Ramsey-Goldman R, Medsger T. Fertility and pregnancy outcome in systemic sclerosis. Arthritis Rheum. 1989;32:S79.
  • Steen V, Medsger T. Natural history of patients with limited systemic sclerosis (IcSSc). Arthritia Rheum. 1989;32:S92.
  • Steen VD, Conte C, Day N, Ramsey-Goldman R, Medsger TA. Pregnancy in women with systemic sclerosis. Arthritis Rheum. 1989;32(2):151-7.
  • Helfrich D, Banner B, Steen V, Medsger T. Normotensive renal failure in systemic sclerosis (scleroderma). Arhtiris Rheum. 1988;31:S51.
  • Kostis JB, Seibold JR, Turkevich D, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med. 1988;84(6):1007-15.
  • Oddis C, Conte C, Casterline G, Steen C, Medsger T. Pregnancy in systemic sclerosis. . 1988.
  • Owens GR, Medsger TA. Systemic sclerosis secondary to occupational exposure. Am J Med. 1988;85(1):114-6.
  • Reimer G, Steen VD, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988;31(4):525-32.
  • Silverstein JL, Steen VD, Medsger TA, Jr., Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol. 1988;124(9):1379-82.
  • Steen VD, Powell DL, Medsger TA, Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988;31(2):196-203.
  • Trostle DC, Bedetti CD, Steen VD, Al-Sabbagh MR, Zee B, Medsger TA, Jr. Renal vascular histology and morphometry in systemic sclerosis. A case- control autopsy study. Arthritis Rheum. 1988;31(3):393-400.
  • Jones NF, Imbriglia JE, Steen VD, Medsger TA. Surgery for scleroderma of the hand. J Hand Surg [Am]. 1987;12(3):391-400.
  • Medsger T. Systemic sclerosis: current concepts of classification and pathogenesis. Connective Tissue. 1987;19:55-59.
  • Miller E, Hiserodt J, Steen V, Medsger T. Decreased natural killer cells (NK) function in systemic sclerosis. Arthritis Rheum. 1987;30:S97.
  • Oddis CV, Eisenbeis CH, Reidbord HE, Steen VD, Medsger TA. Vasculitis in systemic sclerosis: association with Sjogren's syndrome and the CREST syndrome variant. J Rheumatol. 1987;14(5):942-8.
  • Kahl LE, Medsger TA, Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol. 1986;13(1):103-7.
  • Steen VD, Blair S, Medsger TA, Jr. The toxicity of D-penicillamine in systemic sclerosis. Ann Intern Med. 1986;104(5):699-705.
  • Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA, Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986;29(4):515-24.
  • Follansbee WP, Curtiss EI, Rahko PS, et al. The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med. 1985;79(2):183-92.
  • Gerbracht DD, Steen VD, Ziegler GL, Medsger TA, Rodnan GP. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum. 1985;28(1):87-92.
  • Roumm AD, Medsger TA, Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum. 1985;28(12):1336-40.
  • Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA, Jr. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum. 1985;28(7):759-67.
  • Steen VD, Owens GR, Redmond C, Rodnan GP, Medsger TA, Jr. The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum. 1985;28(8):882-8.
  • Trostle D, Bedetti C, Steen V, Al-Sabbagh R, Medsger T. Renal vascular histology and morphometry in systemic subsets: A case-controlled autopsy study. Arthritis Rheum. 1985;28:S80.
  • Brandwein SR, Medsger TA, Jr., Skinner M, Sipe JD, Rodnan GP, Cohen AS. Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1984;43(4):586-9.
  • Follansbee WP, Curtiss EI, Medsger TA, Jr., Owens GR, Steen VD, Rodnan GP. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med. 1984;77(3):489-96.
  • Follansbee WP, Curtiss EI, Medsger TA, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984;310(3):142-8.
  • Graham G, Steen V, Owens G, Medsger T. Follow-up of patients with an isolated diffusing capacity adnormality. Arthritis Rheum. 1984;27:S75.
  • Powell D, Lipisnki E, Steen V, Rodnan G, Medsger T. Clinical associations of anti-SCL 70 antibody in patients with systemic sclerosis. Arthritis Rheum. 1984;27:S19.
  • Roumm AD, Whiteside TL, Medsger TA, Jr., Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum. 1984;27(6):645-53.
  • Steen VD, Medsger TA, Jr., Osial TA, Jr., Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med. 1984;76(5):779-86.
  • Steen VD, Ziegler GL, Rodnan GP, Medsger TA, Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984;27(2):125-31.
  • Follansbee W, Curtiss E, Medsger T, Steen V, Owens G, Rodnan G. An evaluation of cardiac function in progressive systemic sclerosis (pss) with crest. Arthritis RheUM. 1983;26:S26.
  • Medsger TA. Progressive systemic sclerosis. Clin Rheum Dis. 1983;9(3):655-70.
  • Owens GR, Fino GJ, Herbert DL, et al. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest. 1983;84(5):546-50.
  • Roumm A, Whiteside W, Medsger T, Rodnan G. Quantitation and subtyping of lymphocytes in skin and peripheral blood (PB). Arthritis Rheum. 1983;26:S61.
  • Whiteside TL, Medsger TA, Jr., Rodnan GP. HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol. 1983;10(1):128-31.
  • Farrell DA, Medsger TA, Jr. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med. 1982;73(1):57-62.
  • Feigenbaum PA, Medsger TA, Kraines RG, Fries JF. The variability of immunologic laboratory tests. J Rheumatol. 1982;9(3):408-14.
  • Follansbee W, Steen V, Gamble W, Uretsly B, Rodnan G, Medsger T. Cardiac involvement in progressive systemic sclerosis (PSS) assessed by exercise. Arthritis Rheum. 1982;25:S5.
  • Gerbracht D, Steen V, Ziegler G, Medsger T. Evolution of primary Raynaud's phenomenon to connective disease (ctd). Arthritis Rheum. 1982;25:S46.
  • Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25(6):601-11.
  • Lynch CJ, Singh G, Whiteside TL, Rodnan GP, Medsger TA, Jr., Rabin BS. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol. 1982;2(4):314-8.
  • Seibold JR, Medsger TA, Jr., Winkelstein A, Kelly RH, Rodnan GP. Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1982;25(10):1167-73.
  • Steen V, Ziegler G, Rodnan G, Medsger T. Clinical associations of anti-centromere antibody (ACA) in patients with progressive systemic sclerosis. Arthritis Rheum. 1982;25:S4.
  • Steen VD, Medsger TA, Jr., Rodnan GP. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med. 1982;97(5):652-9.
  • Steen V, Medsger T. Beneficial effects of D-peninillamine in progressive systemic sclerosis. . 1981.
  • Masi A, Rodnan G, Medsger T. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
  • Masi A, Rodnan G, Medsger T. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581-90.
  • Medsger T, Steen V, Ziegler G. The natural history of skin involvement in progressive systemic sclerosis. Arthritis Rheum. 1980;23:720-721.
  • Steen V, Medsger T, Ziegler G, Rodnan G. Clinical comparison of two variants of progressive systemic sclerosis (PSS). Arthritis Rheum. 1980;23:752.
  • Masi A, Medsger T, Rodnan G. Methods and preliminary results of the scleroderma criteria cooperative study. Clin Rheum Dis. 1979;5:27-48.
  • Medsger T, Masi A. The epidemiology of systemic sclerosis (Scleroderma) among male US veterans. J Chron Dis. 1978;31:73-85
 

ARAMIS |  Investigators |  Research |  Publications |  HAQ |  Pharmaceutical Collaborations

©2003 Stanford University. All Rights Reserved. If you experience any difficulty with this site, please email our webmaster. Last updated May 2003.